Avastin Regimen Improves Survival in Ovarian Cancer, Including Some HRD-Positive Tumors
June 3rd 2023A progression-free survival benefit was observed in patients with advanced ovarian cancer including those with homologous recombination deficient-positive status who were treated with frontline chemo plus Avastin and Imfinzi followed by maintenance therapy with an Avastin regimen.